1. Home
  2. JLS vs TMCI Comparison

JLS vs TMCI Comparison

Compare JLS & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Mortgage and Income Fund

JLS

Nuveen Mortgage and Income Fund

HOLD

Current Price

$18.45

Market Cap

100.9M

Sector

Finance

ML Signal

HOLD

Logo Treace Medical Concepts Inc.

TMCI

Treace Medical Concepts Inc.

HOLD

Current Price

$2.07

Market Cap

120.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JLS
TMCI
Founded
2009
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
100.9M
120.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
JLS
TMCI
Price
$18.45
$2.07
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
$4.21
AVG Volume (30 Days)
19.6K
579.3K
Earning Date
01-01-0001
04-03-2026
Dividend Yield
9.33%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$209,357,000.00
Revenue This Year
N/A
$3.30
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.89
52 Week Low
$16.80
$1.81
52 Week High
$19.25
$9.53

Technical Indicators

Market Signals
Indicator
JLS
TMCI
Relative Strength Index (RSI) 46.36 45.24
Support Level $18.37 $1.81
Resistance Level $18.48 $3.06
Average True Range (ATR) 0.14 0.15
MACD -0.04 0.03
Stochastic Oscillator 12.26 55.56

Price Performance

Historical Comparison
JLS
TMCI

About JLS Nuveen Mortgage and Income Fund

Nuveen Mortgage And Income Fund is a diversified, closed-end management investment company. The fund invests at least fifty percent of its Managed Assets in MBS, including residential MBS and commercial MBS, and up to fifty percent in non-mortgage related ABS. Its investment objective to generate high current income through opportunistic investments in securitized credit.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Share on Social Networks: